NCT02017366

Design of the EFECTS Trial

Design of the EFECTS Trial, Investigating the Influence of Postoperative Enteral Feeding in Esophageal Cancer paTients on Survival

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University Hospital, Gasthuisberg · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

It is well known that there is a considerable postoperative weight loss in patients undergoing esophageal resection for cancer. We believe that this weigh loss can be limited by administering postoperative enteral feeding (target: 1000 kCal/ day) via feeding jejunostomy for at least 6 weeks postoperatively. We hypothesize that patients undergoing esophageal resection for cancer will have a better overall survival with postoperative additional enteral feeding than when on regular oral diet alone.

Conditions

• Esophageal Cancer

Interventions

Type	Name	Description
OTHER	Enteral feeding	Target of 1000 kCal/day enteral feeding or glucose 20%, perferably given overnight.

Timeline

• Start date: 2018-10-01
• Primary completion: 2021-10-01
• Completion: 2022-04-01
• First posted: 2013-12-20
• Last updated: 2023-12-06

Locations

1 site across 1 country: Belgium